Nanoviricides NNVC
NYSE NNVC
$1.01 -0.02 (-2.39%)
As of: Sep 10, 2026 · 3:59 PM EDT

Nanoviricides (NNVC) Receivables - Other (2014)

Nanoviricides' (NNVC) quarterly Receivables - Other came in at $110578.0 in Q3 2014, down 97.54% quarter-over-quarter from $4.5 million in Q2 2014.

Analysis

Nanoviricides (NNVC) Receivables - Other (2014) Analysis & Trends

Nanoviricides has disclosed Receivables - Other across 1 years of filings, most recently posting $110578.0 for Q3 2014.

  • In Q3 2014, Receivables - Other changed N/A year-over-year to $110578.0; the TTM figure through Sep 2014 stood at $110578.0 (changed N/A YoY), while the FY2014 annual figure was $4.5 million, changed N/A from the prior year.
  • Receivables - Other came in at $110578.0 for Q3 2014 at Nanoviricides, down from $4.5 million in the prior quarter.
  • In the past five years, Receivables - Other ranged from a high of $4.5 million in Q2 2014 to a low of $110578.0 in Q3 2014.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn
10 Nanoviricides 22.04 Mn 18.83 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2014 110,578.00
Jun 30, 2014 4.50 Mn